Navigation Links
Medifast to Exceed Revenue Guidance for 2008

Company achieves $100 million in revenues through early December

OWINGS MILLS, Md., Dec. 16 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED), a leading provider of easy-to-use, clinically proven portion-controlled weight loss programs, today announced the company will exceed its previously issued revenue guidance for fiscal year 2008. The Company previously guided fiscal 2008 revenues to be in the range of $90.5 million to $92.0 million. The Company now expects revenues in excess of $100 million for fiscal year 2008; a record for the company.

The leading driver of revenue growth continues to be the company's direct sales segment, Take Shape for Life, which through September 30, 2008 experienced revenue increases of 77%, comprising 44% of year-to-date revenues. The Company expects the Take Shape for Life segment to continue on the strong results year-to-date in the fourth quarter of this year.

Col. Brad MacDonald, USMC (Ret.), Chairman of the Board of Medifast Inc., commented, "I am extremely pleased that we have reached a significant milestone in the history of Medifast by achieving $100 million in annual revenues through early December. The growth we have achieved in the current recession mirrors that of past recessions, and reinforces the fact that during tough economic times, consumers turn their attention to improving their health and appearance. In that regard, those who have lost weight on the Medifast program, and desire to help others do the same, can substantially supplement their personal cash flow, in a difficult economic period, through direct sales in our "Take Shape for Life" program. With the Company's track record of 36 consecutive quarters of profitability, we believe that we are well positioned to build on that foundation of success going forward."

Mr. Michael S. McDevitt, Chief Executive Officer of Medifast, Inc. commented, "We are extremely pleased to report that we expect to exceed our previously reported revenue guidance for the year. The investments that we have made throughout 2008 as well as the diversification of the Company's business model to offer a range of clinically-proven solutions through various distribution channels is proving to be successful. We are looking to close fiscal year 2008 on a strong note and look forward to 2009 with great anticipation."

The Company expects financial results for the fourth quarter and year-end to be reported in early March 2009.

About Medifast:

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by more than 15,000 physicians nationwide. The number of customers utilizing the Medifast Weight Loss program exceeds 1 million. Medifast is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the Internet and national call centers; 2) a national network of physicians; 3) medically supervised Medifast Weight Control Centers; and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto

SafeHarbor Statement

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

    Contact:  Brendan Connors
              Vice President - Finance

              Lytham Partners, LLC
              Joe Diaz
              Robert Blum
              Joe Dorame

SOURCE Medifast, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medifast Diversified Business Model Drives Strong Revenue and Earnings Growth for the Third Quarter of 2008
2. Medifast Adds New Crunchy Bars to Product Line
3. Medifast, Inc. to Announce Third Quarter of Fiscal Year 2008 Financial Results on Thursday, November 6, 2008
4. Medifast Announces Opening of First Franchise Clinic
5. Medifast Challenging Dieters to Express Your Success in Video Contest
6. Medifast Announces Second Quarter 2008 Financial Results
7. Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone
8. Medifast Weight Control Centers to Open in California
9. Medifast, Inc. to Present at the Canaccord Adams Diabetes & Obesity Conference
10. Medifast, Inc. Names Barry B. Bondroff, CPA to Board of Directors
11. Medifast Announces First Quarter 2008 Financial Results
Post Your Comments:
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Dr. Rodney E. Willey , has ... new venture, Koala Center for Sleep Disorders, provides treatment for snoring and sleep apnea ... have opened a Koala Center for Sleep Disorders in the US, one of four in ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... and Healthy Aging Program have announced their endorsement of the Medical Fitness ... Health Fitness is proud to have the MFN as one of our endorsed ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Autism Speaks, the ... global movement driven by social media and the generosity of people around the world. ... their social media networks to give – and share the personal stories behind those ...
(Date:11/24/2015)... Miami, FL (PRWEB) , ... November 24, 2015 ... ... manufacturer and engineer of patented products, announces Innovative Blending, a household invention that ... go. , "The Juice & Smoothie Bars market is worth $2 billion," says ...
(Date:11/24/2015)... ... November 24, 2015 , ... Robert Yeager CEO of PharmMD, has ... past year there have been multiple breakthroughs and challenges as healthcare reform moves out ... enabled their customers and partners to stay ahead of the curve by breaking down ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Avery Biomedical Devices (ABD), manufacturer of the ... appointment of Anders Jonzon , MD; Ph.D. as ... Dr. Jonzon is a Physiologist and consultant ... University, Uppsala and Children,s Hospital, Karolinska, Stockholm, ... at the Cardiovascular Institute (UCSF). His research has covered ...
(Date:11/24/2015)... LAUSANNE and BERN, Switzerland ... SA, the ARTORG Center for Biomedical Engineering Research of ... and the Division of Endocrinology, Diabetes and Clinical Nutrition ... announce the start of an exclusive collaboration to develop ... control algorithm for the personalised delivery of insulin for ...
(Date:11/24/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... Education and Human Resources will be presenting in the upcoming ... Plan Strategies for a Dynamic Market" on Dec. 1, 2015. ... consultant with the Cambridge Advisory Group, where she leads their ... The webinar will discuss the rapid growth of oral oncolytics, ...
Breaking Medicine Technology: